Finally, one study from China indicated that the tumor content of circulating cfDNA is related to the development of HBV-related HCC and presents an increasing trend during the 4-year period preceding clinical diagnosis of HCC, whereas it is correlated with tumor burden and worse survival [ 22 ].
← all excerpts
The Current Role of Circulating Cell-Free DNA in the Management of Hepatocellular Carcinoma.
1
—
—